$550,000 of AXON ENTERPRISE lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advocating for state, federal, and tribal law enforcement less-lethal technologies, body worn cameras and digital evidence management HR 2189, law enforcement innovate to de-escalate act S.1283, Innovate to de-escalate modernization act HR 4242, Innovate to De-Escalate Tax Modernization Act HR 3598, De-Escalation Drone Pilot Program Act of 2025 FAA drone and counter policy issues FCC policy related to indoor drones for law enforcement and enforcement of HR 2864 the Countering Drones CCP Act FY26 NDAA less lethal and drone/counter drone policy FY26 DHS/DOJ Appropriations for body worn camera and less lethal technology"
You can find more data on corporate lobbying on Quiver Quantitative.
AXON Congressional Stock Trading
Members of Congress have traded $AXON stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $AXON stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/05 and 1 sale worth up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
AXON Insider Trading Activity
AXON insiders have traded $AXON stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.
Here’s a breakdown of recent trading of $AXON stock by insiders over the last 6 months:
- JOSHUA ISNER (PRESIDENT) has made 0 purchases and 33 sales selling 19,810 shares for an estimated $14,162,650.
- PATRICK W SMITH (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 19 sales selling 10,000 shares for an estimated $5,409,861.
- MICHAEL GARNREITER has made 0 purchases and 2 sales selling 6,000 shares for an estimated $4,560,000.
- BRITTANY BAGLEY (COO & CFO) sold 3,400 shares for an estimated $2,380,000
- CAMERON BROOKS (CHIEF REVENUE OFFICER) sold 3,000 shares for an estimated $2,222,295
- CAITLIN ELIZABETH KALINOWSKI has made 0 purchases and 2 sales selling 2,100 shares for an estimated $1,531,086.
- JERI WILLIAMS has made 0 purchases and 2 sales selling 964 shares for an estimated $629,585.
- JULIE A CULLIVAN sold 657 shares for an estimated $459,900
- MATTHEW R MCBRADY sold 400 shares for an estimated $287,361
- JENNIFER H MAK (Chief Accounting Officer) sold 75 shares for an estimated $57,885
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AXON Hedge Fund Activity
We have seen 555 institutional investors add shares of AXON stock to their portfolio, and 478 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GQG PARTNERS LLC removed 804,867 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $423,319,798
- GAMMA INVESTING LLC removed 763,005 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $631,722,359
- JENNISON ASSOCIATES LLC added 611,418 shares (+23203.7%) to their portfolio in Q1 2025, for an estimated $321,575,297
- BANK OF AMERICA CORP /DE/ added 407,910 shares (+196.8%) to their portfolio in Q1 2025, for an estimated $214,540,264
- JPMORGAN CHASE & CO added 355,664 shares (+82.7%) to their portfolio in Q1 2025, for an estimated $187,061,480
- FMR LLC added 287,195 shares (+12.0%) to their portfolio in Q1 2025, for an estimated $151,050,210
- WINSLOW CAPITAL MANAGEMENT, LLC added 262,254 shares (+inf%) to their portfolio in Q1 2025, for an estimated $137,932,491
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AXON Analyst Ratings
Wall Street analysts have issued reports on $AXON in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 07/17/2025
- Wolfe Research issued a "Outperform" rating on 07/08/2025
- B of A Securities issued a "Buy" rating on 06/04/2025
- Goldman Sachs issued a "Buy" rating on 05/14/2025
- Barclays issued a "Overweight" rating on 05/09/2025
- Needham issued a "Buy" rating on 05/08/2025
- Citizens Capital Markets issued a "Market Outperform" rating on 02/26/2025
To track analyst ratings and price targets for AXON, check out Quiver Quantitative's $AXON forecast page.
AXON Price Targets
Multiple analysts have issued price targets for $AXON recently. We have seen 9 analysts offer price targets for $AXON in the last 6 months, with a median target of $750.0.
Here are some recent targets:
- Paul Chung from JP Morgan set a target price of $850.0 on 07/17/2025
- Andrew Spinola from UBS set a target price of $820.0 on 07/16/2025
- Jordan Lyonnais from B of A Securities set a target price of $895.0 on 06/04/2025
- Michael Ng from Goldman Sachs set a target price of $830.0 on 05/14/2025
- Tim Long from Barclays set a target price of $735.0 on 05/09/2025
- Joshua Reilly from Needham set a target price of $750.0 on 05/08/2025
- Daniel Stauder from Citizens Capital Markets set a target price of $725.0 on 02/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
